SynthesisFrontiers in oncology2025
Frontier and hotspots in the role of sentinel lymph node in endometrial cancer based on bibliometric analysis.
Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The role of sentinel lymph nodes (SLN) in endometrial cancer remains controversial. Our study is dedicated to employing bibliometric methods to explore the correlation between endometrial cancer and SLN. We aim to statistically analyze the existing literature on sentinel lymph nodes in the field of endometrial cancer research and explore future research trends and hotspots. Global literature on the role of SLN in endometrial cancer published from 1900 to the present in the Web of Science core database was searched. Cited articles were focused on by extracting information such as country, journal, keywords, institution and author. Descriptive statistics and visual analysis were performed using VOSviewer and R package. A total of 545 articles were screened, most of which were from USA (159 articles). Based on Bradford Law, Gynecologic Oncology and International Journal of Gynecological Cancer were core journals in this research field. Abu-Rustum Nadeem R from Mem Sloan Kettering Cancer Center was most productive author. The current research focus was endometrial cancer, SLN, lymphadenectomy, biopsy, indocyanine green (ICG). The complication, guidelines, outcomes and survival were the frontier of current research. Researchers in different countries have paid extensive attention to the role of SLN in the treatment of endometrial cancer, and have made breakthroughs in this field. SLN mapping has a promising prospect for the recurrence and prognosis of patients with endometrial cancer. More clinical research is needed to discover the role of SLN in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.